The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: Results of a prospective observational study

At predicts a better survival in patients with advanced NSCLC. The prognostic value is more stringent for stage III patients. Inclusion of At as a negative prognostic factor in the TNM staging system warrants further evaluation.